Skip to main content

Table 1 Clinical characteristics at baseline

From: Hetrombopag plus porcine ATG and cyclosporine for the treatment of aplastic anaemia: early outcomes of a prospective pilot study

 

Hetrombopag group (n = 32)

Control group (n = 96)

P value

Age (years, median, range)

44 (13–69)

45 (7–70)

0.928

Gender (male/female)

17/15

52/44

0.919

Severity of aplastic anaemia, n (%)

 Severe

21 (66%)

60 (63%)

0.752

 Very severe

11 (34%)

36 (37%)

Complete blood count (median, range)

 Reticulocyte count (×109/L)

15.2 (0.2–68.4)

12.9 (0–63.7)

0.821

 Neutrophil count (×109/L)

0.33 (0–1.04)

0.33 (0–1.12)

0.739

 Platelet count (×109/L)

7 (1–21)

8 (0–31)

0.361

 Haemoglobin level (g/L)

55 (34–99)

61 (33–96)

0.046

PNH clones (+), n (%)

11 (34%)

26 (27%)

0.433

  1. Hetrombopag group: IST plus hetrombopag; control group: IST alone